NEOVASC INC
DelistedCIK 1399708fmd_0Q6BWXZKW1GM8VD2QQX78PE1KQManufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard
Coverage: Jan 01, 2015 to Dec 31, 2021, 7 periods
Latest annual · FY2021
Millions- Total revenues
- 3
- Gross profit
- 2
- Operating income
- (31)
- Net income
- (25)
- Free cash flow
- (27)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2018 to FY2021
- +13.4%
- Revenue, 5 yearsFY2016 to FY2021
- -23.2%
- Net income, 5 yearsFY2016 to FY2021
- n/m
NEOVASC INC financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2021 | FY2020 | Change | Source |
|---|---|---|---|---|
| Revenue | $2.5 million | $2 million | +30.1% | 20-F 2022-03-10 · proof |
| Gross profit | $2 million | $1.5 million | +31.8% | 20-F 2022-03-10 · proof |
| Operating income | -$31.1 million | -$35.2 million | 20-F 2022-03-10 · proof | |
| Net income | -$24.9 million | -$28.7 million | 20-F 2022-03-10 · proof | |
| Cash from operating activities | -$27.1 million | -$29.4 million | 20-F 2022-03-10 · proof | |
| Free cash flow | -$27.3 million | -$29.8 million | 20-F 2022-03-10 · proof | |
| Total assets | $66.2 million | $17.9 million | +270.4% | 20-F 2022-03-10 · proof |
| Total liabilities | $14 million | $15.9 million | -12% | 20-F 2022-03-10 · proof |
| Cash and cash equivalents | $51.5 million | $12.9 million | +298.4% | 20-F 2022-03-10 · proof |
- What was NEOVASC INC's revenue in fiscal 2021?
- NEOVASC INC reported revenue of $2.5 million for fiscal 2021 (the year ended Dec 31, 2021), against $2 million the year before (+30.1%). Source: the 20-F filed with the SEC on Mar 10, 2022. SEC
- What was NEOVASC INC's gross profit in fiscal 2021?
- NEOVASC INC reported gross profit of $2 million for fiscal 2021 (the year ended Dec 31, 2021), against $1.5 million the year before (+31.8%). Source: the 20-F filed with the SEC on Mar 10, 2022. SEC
- What was NEOVASC INC's operating income in fiscal 2021?
- NEOVASC INC reported operating income of -$31.1 million for fiscal 2021 (the year ended Dec 31, 2021), against -$35.2 million the year before. Source: the 20-F filed with the SEC on Mar 10, 2022. SEC
- What was NEOVASC INC's net income in fiscal 2021?
- NEOVASC INC reported net income of -$24.9 million for fiscal 2021 (the year ended Dec 31, 2021), against -$28.7 million the year before. Source: the 20-F filed with the SEC on Mar 10, 2022. SEC
- What was NEOVASC INC's cash from operating activities in fiscal 2021?
- NEOVASC INC reported cash from operating activities of -$27.1 million for fiscal 2021 (the year ended Dec 31, 2021), against -$29.4 million the year before. Source: the 20-F filed with the SEC on Mar 10, 2022. SEC
- What was NEOVASC INC's free cash flow in fiscal 2021?
- NEOVASC INC reported free cash flow of -$27.3 million for fiscal 2021 (the year ended Dec 31, 2021), against -$29.8 million the year before. Source: the 20-F filed with the SEC on Mar 10, 2022. SEC
- What are NEOVASC INC's total assets?
- As of Dec 31, 2021, NEOVASC INC reported total assets of $66.2 million, against $17.9 million a year earlier (+270.4%). Source: the 20-F filed with the SEC on Mar 10, 2022. SEC
- What are NEOVASC INC's total liabilities?
- As of Dec 31, 2021, NEOVASC INC reported total liabilities of $14 million, against $15.9 million a year earlier (-12%). Source: the 20-F filed with the SEC on Mar 10, 2022. SEC
- What are NEOVASC INC's cash and cash equivalents?
- As of Dec 31, 2021, NEOVASC INC reported cash and cash equivalents of $51.5 million, against $12.9 million a year earlier (+298.4%). Source: the 20-F filed with the SEC on Mar 10, 2022. SEC
Read from the FinancialMD API on Nov 14, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1399708&period_type=annual&limit=5"Information only, not investment advice.